Artificial Intelligence Artificial intelligence technology empowers us to see more and predict better. Data sets that were previously too large or time consuming to analyze can now be included in clinical decisions. Read more about our activities and insights on Artificial Intelligence.
Amsterdam UMC
Topic
Artikelen over Alzheimer Alzheimer’s disease is a type of dementia. Alzheimer Center Amsterdam aims to find ways to discuss, treat and cure Alzheimer’s disease and other types of dementia. Read here about our latest insights and activities.
Amsterdam UMC
Topic
Cardiovascular Diseases Cardiovascular failure is the most frequent cause of hospitalization in Western societies. We work toward preventing and curing cardiovascular diseases. Read about our activities and insights on cardiovascular diseases.r
.
Amsterdam UMC
Topic
Artikelen over beeldvormende technieken Imaging is an indispensable tool for diagnosing, investigating, predicting, and treating. Innovations in the field of imaging provide (future) patients and researchers with new opportunities, such as a faster diagnosis or an improved assessment to determine which treatment is most effective. Read about our activities and insights on imaging..
Amsterdam UMC
Topic
Collaboration Together with experts from other (inter)national organizations, we aim to ensure that every patient is cared for by the most suitable medical professionals and can beneft from latest insights. Read more about our activities and insights on collaboration
Amsterdam UMC
Topic
Artikelen over het afweersysteem The immune sytem protects our body against infectious diseases caused by bacterias, viruses and fungi. Vaccines can help the immune system.
.
Medicines & drug development Which drugs are most suitable for which patient? Which combinations of drugs work best? Can drugs be more afforable? Read about our latest activities and insights here,
Amsterdam UMC
Topic
Nieuws
Clot dissolver after stroke makes no difference for recovery Patients with acute ischemic stroke do not recover better if they are given a clot-dissolving drug before further treatment. This finding has been the result of a large international study of neurologists and radiologists from 20 hospitals. The research was carried out within the CONTRAST consortium and coordinated by Amsterdam UMC. The findings were published in the scientific journal The New England Journal of Medicine.
